Related references
Note: Only part of the references are listed.Cardiovascular risk estimation in older persons: SCORE OP
Marie Therese Cooney et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome A Narrative Review
Eliano P. Navarese et al.
ANNALS OF INTERNAL MEDICINE (2016)
Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents
Xin-Lin Zhang et al.
ANNALS OF INTERNAL MEDICINE (2016)
Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)
Sarah D. de Ferranti et al.
CIRCULATION (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults
Kimber L. Stanhope et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies
Pernille L. B. Holloender et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention
Goran Loncar et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2015)
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Marja-Riitta Taskinen et al.
ATHEROSCLEROSIS (2015)
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society
Charalambos Vlachopoulos et al.
ATHEROSCLEROSIS (2015)
The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30 824 Europeans: the Copenhagen General Population Study
Martin B. Mortensen et al.
EUROPEAN HEART JOURNAL (2015)
Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment
Handrean Soran et al.
EUROPEAN HEART JOURNAL (2015)
Cardiovascular disease in Europe - epidemiological update 2015
Nick Townsend et al.
EUROPEAN HEART JOURNAL (2015)
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
Albert Wiegman et al.
EUROPEAN HEART JOURNAL (2015)
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
Erik S. Stroes et al.
EUROPEAN HEART JOURNAL (2015)
Effects of add-on lipid-modifying therapy on top of background statin treatment on major cardiovascular events: A meta-analysis of randomized controlled trials
Chi-kin Ip et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
Jiarong Lan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
Statin use and non-alcoholic steatohepatitis in at risk individuals
Paola Dongiovanni et al.
JOURNAL OF HEPATOLOGY (2015)
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention The Multicenter Randomized Controlled PRECISE-IVUS Trial
Kenichi Tsujita et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Clinician-Patient Risk Discussion for Atherosclerotic Cardiovascular Disease Prevention
Seth S. Martin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
Jordan Fulcher et al.
LANCET (2015)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality
Gregory A. Roth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys
Kaveh Hajifathalian et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
Alexis Ogdie et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 Countries
Marta Futema et al.
CLINICAL CHEMISTRY (2015)
Mendelian randomization of blood lipids for coronary heart disease
Michael V. Holmes et al.
EUROPEAN HEART JOURNAL (2015)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2015)
Comparing Different Policy Scenarios to Reduce the Consumption of Ultra-Processed Foods in UK: Impact on Cardiovascular Disease Mortality Using a Modelling Approach
Patricia V. L. Moreira et al.
PLOS ONE (2015)
What proportion of symptomatic side-effects in patients taking statins are genuinely caused by the drug? A response to letters
Judith A. Finegold et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study
Sumeet Subherwal et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Theory of planned behavior and adherence in chronic illness: a meta-analysis
Antonia Rich et al.
JOURNAL OF BEHAVIORAL MEDICINE (2015)
Guidelines for Classificattion of Acute Kidney Diseases aid Disorders
Rebecca Barry et al.
NEPHRON (2015)
Impact of High-Dose Atorvastatin Therapy and Clinical Risk Factors on Incident Aortic Valve Stenosis in Patients With Cardiovascular Disease (from TNT, IDEAL, and SPARCL)
Benoit J. Arsenault et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Statins and Contrast-induced Acute Kidney Injury with Coronary Angiography
Sumeet Gandhi et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Diets to Prevent Coronary Heart Disease 1957-2013: What Have We Learned?
James E. Dalen et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Lipid Management in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2013 Clinical Practice Guideline
Marcello Tonelli et al.
ANNALS OF INTERNAL MEDICINE (2014)
Targeting PCSK9 for Hypercholesterolemia
Giuseppe Danilo Norata et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Lysosomal acid lipase deficiency - An under-recognized cause of dyslipidaemia and liver dysfunction
Zeljko Reiner et al.
ATHEROSCLEROSIS (2014)
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease
Helena Gylling et al.
ATHEROSCLEROSIS (2014)
Combination therapy in dyslipidemia: Where are we now?
Alberico L. Catapano et al.
ATHEROSCLEROSIS (2014)
Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group
Michel R. Langlois et al.
ATHEROSCLEROSIS (2014)
Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials
Constance Gayet-Boyer et al.
BRITISH JOURNAL OF NUTRITION (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
CIRCULATION (2014)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff et al.
CIRCULATION (2014)
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Robert H. Eckel et al.
CIRCULATION (2014)
Impact of Early Evidence of Atherosclerotic Changes on Early Treatment in Children With Familial Hypercholesterolemia
Zeljko Reiner
CIRCULATION RESEARCH (2014)
Economic Evaluation of Primary Prevention of Cardiovascular Diseases in Mild Hypertension: A Scenario Analysis for the Netherlands
Jelena Stevanovic et al.
CLINICAL THERAPEUTICS (2014)
Primary Prevention of Cardiovascular Disease with Statins in the Elderly
Zeljko Reiner
CURRENT ATHEROSCLEROSIS REPORTS (2014)
Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin
Ling He et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review
C. P. Ooi et al.
DIABETIC MEDICINE (2014)
Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Michael C. d'Emden et al.
DIABETOLOGIA (2014)
Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study
Alex McConnachie et al.
EUROPEAN HEART JOURNAL (2014)
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry
Dharam J. Kumbhani et al.
EUROPEAN HEART JOURNAL (2014)
HIV infection and cardiovascular disease
Lars G. Hemkens et al.
EUROPEAN HEART JOURNAL (2014)
Seasonality of cardiovascular risk factors: an analysis including over 230 000 participants in 15 countries
Helena Marti-Soler et al.
HEART (2014)
Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)
John Deanfield et al.
HEART (2014)
Long-term Follow-up After Bariatric Surgery A Systematic Review
Nancy Puzziferri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Patrick M. Moriarty et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa for Lowering Very high triglyceridEs (EVOLVE) trial
John J. P. Kastelein et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Metabolic Syndrome in a French Cohort of Patients With Bipolar Disorder: Results From the FACE-BD Cohort
Ophelia Godin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a) Prospective 15-Year Outcomes in the Bruneck Study
Peter Willeit et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Association Between Statin Medications and Mortality, Major Adverse Cardiovascular Event, and Amputation-Free Survival in Patients With Critical Limb Ischemia
Gregory G. Westin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials
S. Matthijs Boekholdt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
A Polypill Strategy to Improve Adherence Results From the FOCUS Project
Jose M. Castellano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance
Erik Stroes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
Pia R. Kamstrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Triglycerides and cardiovascular disease
Borge G. Nordestgaard et al.
LANCET (2014)
Type 1 diabetes, metabolic syndrome and cardiovascular risk
Juan J. Chillaron et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Changes in Diabetes-Related Complications in the United States, 1990-2010
Edward W. Gregg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
Martin J. Landray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease
Nathan O. Stitziel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Association of fructose consumption and components of metabolic syndrome in human studies: A systematic review and meta-analysis
Roya Kelishadi et al.
NUTRITION (2014)
Resistance and intolerance to statins
Z. Reiner
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
A Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Four Eastern Mediterranean Countries
Helen Mason et al.
PLOS ONE (2014)
A Meta-Analysis of Red Yeast Rice: An Effective and Relatively Safe Alternative Approach for Dyslipidemia
Yinhua Li et al.
PLOS ONE (2014)
An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England: A Policy Modeling Study
Marissa Collins et al.
VALUE IN HEALTH (2014)
The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies
Jana V. van Vliet-Ostaptchouk et al.
BMC ENDOCRINE DISORDERS (2014)
Open letter raises concerns about NICE guidance on statins
Jacqui Wise
BMJ-BRITISH MEDICAL JOURNAL (2014)
GUIDELINES Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance
Silvia Rabar et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
Daniel Keene et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys
Renata Micha et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Insights Into Aortic Sclerosis and Its Relationship With Coronary Artery Disease
Alexandra C. Milin et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study
Christoph U. Correll et al.
JAMA PSYCHIATRY (2014)
Diabetes: a 21st century challenge
Paul Z. Zimmet et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Robert A. Hegele et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations The CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)
Jennifer K. Rogers et al.
JACC-HEART FAILURE (2014)
Determinants of patients adherence to hypertension medications: Application of health belief model among rural patients
A. Kamran et al.
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2014)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
EUROPEAN HEART JOURNAL (2014)
Gender and racial disparities in adherence to statin therapy: A meta-analysis
Jennifer Lewey et al.
AMERICAN HEART JOURNAL (2013)
Role of Colesevelam in Combination Lipid-Lowering Therapy
Michael R. Jones et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2013)
Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults A Cohort Study
Dariush Mozaffarian et al.
ANNALS OF INTERNAL MEDICINE (2013)
Intermittent Nondaily Dosing Strategies in Patients with Previous Statin-Induced Myopathy
Alyssa J. Keating et al.
ANNALS OF PHARMACOTHERAPY (2013)
Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks
Xin-Min Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins
Chittaranjan Andrade
BIPOLAR DISORDERS (2013)
Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008
Belgin Unal et al.
BMC PUBLIC HEALTH (2013)
Effect of Statins on Skeletal Muscle Function
Beth A. Parker et al.
CIRCULATION (2013)
Apolipoprotein C-III Going Back to the Future for a Lipid Drug Target
Murray W. Huff et al.
CIRCULATION RESEARCH (2013)
Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
Mark J. Graham et al.
CIRCULATION RESEARCH (2013)
Comparative Tolerability and Harms of Individual Statins: A Study-Level Network Meta-Analysis of 246 955 Participants From 135 Randomized, Controlled Trials
Huseyin Naci et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
Explaining the Decline in Coronary Heart Disease Mortality in Portugal Between 1995 and 2008
Marta Pereira et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
Acute Coronary Syndromes in Patients with Chronic Kidney Disease
Beata Franczyk-Skora et al.
CURRENT VASCULAR PHARMACOLOGY (2013)
Revisiting the links between glycaemia, diabetes and cardiovascular disease
N. Sattar
DIABETOLOGIA (2013)
Update on acute coronary syndromes: the pathologists view
Erling Falk et al.
EUROPEAN HEART JOURNAL (2013)
Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
Anders Berg Jorgensen et al.
EUROPEAN HEART JOURNAL (2013)
Stroke and coronary heart disease: predictive power of standard risk factors into old age-long-term cumulative risk study among men in Gothenburg, Sweden
KokWai Giang et al.
EUROPEAN HEART JOURNAL (2013)
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2013)
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
D. Gaudet et al.
GENE THERAPY (2013)
Developing and evaluating complex interventions: The new Medical Research Council guidance
Peter Craig et al.
INTERNATIONAL JOURNAL OF NURSING STUDIES (2013)
The risk of atherosclerosis in patients with chronic kidney disease
Sylwia Olechnowicz-Tietz et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2013)
Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD The UMPIRE Randomized Clinical Trial
Simon Thom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Effect of Statin Therapy on the Progression of Common Carotid Artery Intima-Media Thickness: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Yubei Huang et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2013)
Lipoprotein(a): resurrected by genetics
F. Kronenberg et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
Kevin F. Erickson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction
Pia R. Kamstrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy Effect of Baseline Risk Factors for Diabetes
David D. Waters et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease A Meta-Analysis
Gianluigi Savarese et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Anette Varbo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial
Theodore M. Brasky et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Ron T. Gansevoort et al.
LANCET (2013)
Common variants associated with plasma triglycerides and risk for coronary artery disease
Ron Do et al.
NATURE GENETICS (2013)
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer et al.
NATURE GENETICS (2013)
被撤回的出版物: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet (Retracted article. See vol. 378, pg. 2441, 2018)
Ramon Estruch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A daily glass of red wine associated with lifestyle changes independently improves blood lipids in patients with carotid arteriosclerosis: results from a randomized controlled trial
Dirk W. Droste et al.
NUTRITION JOURNAL (2013)
Low glycaemic index diets and blood lipids: A systematic review and meta-analysis of randomised controlled trials
L. M. Goff et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
PATHOPHYSIOLOGY OF HUMAN VISCERAL OBESITY: AN UPDATE
Andre Tchernof et al.
PHYSIOLOGICAL REVIEWS (2013)
Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review
Clay Bavinger et al.
PLOS ONE (2013)
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy-A meta-analysis of 11 randomized controlled trials involving 21,295 participants
Marcin Barylski et al.
PHARMACOLOGICAL RESEARCH (2013)
Reduction in Early Stroke Risk in Carotid Stenosis With Transient Ischemic Attack Associated With Statin Treatment
Aine Merwick et al.
STROKE (2013)
Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland
Celine O'Keeffe et al.
BMJ OPEN (2013)
Should people at low risk of cardiovascular disease take a statin?
John D. Abramson et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
Olov Wiklund et al.
CURRENT CARDIOLOGY REPORTS (2013)
The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change Interventions
Susan Michie et al.
ANNALS OF BEHAVIORAL MEDICINE (2013)
Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in Studies of a Targeted Risk Reduction Intervention through Defined Exercise I
Kim M. Huffman et al.
AMERICAN HEART JOURNAL (2012)
Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
Jennifer G. Robinson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
Christie M. Ballantyne et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
FDA Drug Safety Communications: A Narrative Review and Clinical Considerations for Older Adults
Zachary A. Marcum et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2012)
Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients
Sayed H. Naderi et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification A Cohort Study
Maryam Kavousi et al.
ANNALS OF INTERNAL MEDICINE (2012)
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
Torbjorn Wisloff et al.
BMC CARDIOVASCULAR DISORDERS (2012)
Healthy Lifestyle Through Young Adulthood and the Presence of Low Cardiovascular Disease Risk Profile in Middle Age The Coronary Artery Risk Development in (Young) Adults (CARDIA) Study
Kiang Liu et al.
CIRCULATION (2012)
Body Fat Distribution and Risk of Cardiovascular Disease An Update
Jean-Pierre Despres
CIRCULATION (2012)
Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial
Daniel I. Chasman et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
Omega 3 Fatty Acids and Cardiovascular Outcomes Systematic Review and Meta-Analysis
Sradha Kotwal et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study
Markus Herrmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases
Michal Tendera et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010
Chris P. Gale et al.
EUROPEAN HEART JOURNAL (2012)
Better treatment and improved prognosis in elderly patients with AMI: but do registers tell the whole truth?
Annika Rosengren
EUROPEAN HEART JOURNAL (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Effects of Statin Therapy on Abdominal Aortic Aneurysm Growth: A Meta-analysis and Meta-regression of Observational Comparative Studies
H. Takagi et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2012)
Lipid-Related Markers and Cardiovascular Disease Prediction
Emanuele Di Angelantonio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis
S. Matthijs Boekholdt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events A Systematic Review and Meta-analysis
Evangelos C. Rizos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals
Joseph Yeboah et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication
Marianne Benn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Lars Berglund et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other Lipids: A review
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Effects of Fibrates in Kidney Disease
Min Jun et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
Lifetime Risks of Cardiovascular Disease
Jarett D. Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors
F. L. Santos et al.
OBESITY REVIEWS (2012)
A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose
Bjorn Lindkvist et al.
PANCREATOLOGY (2012)
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
Jonathan R. Emberson et al.
PLOS ONE (2012)
Which Interventions Offer Best Value for Money in Primary Prevention of Cardiovascular Disease?
Linda J. Cobiac et al.
PLOS ONE (2012)
Statin Therapy and the Risk of Intracerebral Hemorrhage A Meta-Analysis of 31 Randomized Controlled Trials
James S. McKinney et al.
STROKE (2012)
Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach
Hema Mistry et al.
BMJ OPEN (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
EUROPEAN HEART JOURNAL (2012)
Medication adherence: A call for action
Hayden B. Bosworth et al.
AMERICAN HEART JOURNAL (2011)
Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
Harold E. Bays et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Statins for Cardiovascular Prevention According to Different Strategies A Cost Analysis
Marcia K. Ito et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2011)
Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study
Mary A. De Vera et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia
Christopher T. Johansen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases
Giovanni Corrao et al.
ATHEROSCLEROSIS (2011)
Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis
Meng Lee et al.
ATHEROSCLEROSIS (2011)
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study
Philippe Latry et al.
BMC CARDIOVASCULAR DISORDERS (2011)
Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention A Collaborative Patient-Level Meta-Analysis of 13 Randomized Studies
Giuseppe Patti et al.
CIRCULATION (2011)
Forecasting the Future of Cardiovascular Disease in the United States A Policy Statement From the American Heart Association
Paul A. Heidenreich et al.
CIRCULATION (2011)
A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
Allan D. Sniderman et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Nonfasting Lipids, Lipoproteins, and Apolipoproteins in Individuals with and without Diabetes: 58 434 Individuals from the Copenhagen General Population Study
Anne Langsted et al.
CLINICAL CHEMISTRY (2011)
Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
Melissa Y. Wei et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
Diagnostic Value of Postprandial Triglyceride Testing in Healthy Subjects: A Meta-Analysis
Constantinos Mihas et al.
CURRENT VASCULAR PHARMACOLOGY (2011)
Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
Genovefa D. Kolovou et al.
Current Vascular Pharmacology (2011)
Statins and renovascular disease in the elderly: a population-based cohort study
Daniel G. Hackam et al.
EUROPEAN HEART JOURNAL (2011)
ESC/EAS GUIDELINES ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2011)
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
Jose R. Banegas et al.
EUROPEAN HEART JOURNAL (2011)
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. John Chapman et al.
EUROPEAN HEART JOURNAL (2011)
The behaviour change wheel: A new method for characterising and designing behaviour change interventions
Susan Michie et al.
IMPLEMENTATION SCIENCE (2011)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis
Eric Bruckert et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Factors associated with reaching 90 years of age: a study of men born in 1913 in Gothenburg, Sweden
L. Wilhelmsen et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin
Judith Hsia et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The Effect of Mediterranean Diet on Metabolic Syndrome and its Components A Meta-Analysis of 50 Studies and 534,906 Individuals
Christina-Maria Kastorini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial
R. Bulbulia et al.
LANCET (2011)
Medication Adherence: WHO Cares?
Marie T. Brown et al.
MAYO CLINIC PROCEEDINGS (2011)
Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
Amy Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Developing and testing the health literacy universal precautions toolkit
Darren A. DeWalt et al.
NURSING OUTLOOK (2011)
Non-soy legume consumption lowers cholesterol levels: A meta-analysis of randomized controlled trials
L. A. Bazzano et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report
PEDIATRICS (2011)
A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-analysis of randomized, placebo-controlled trials
Kathy Musa-Veloso et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
E. J. Mills et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2011)
Life expectancy among persons with schizophrenia or bipolar affective disorder
Thomas Munk Laursen
SCHIZOPHRENIA RESEARCH (2011)
The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
Paul F. van Gils et al.
BMJ OPEN (2011)
United Nations' dietary policies to prevent cardiovascular disease
Dariush Mozaffarian et al.
BRITISH MEDICAL JOURNAL (2011)
Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies
Susan E. Brien et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)
Michal Tendera et al.
EUROPEAN HEART JOURNAL (2011)
ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
EUROPEAN HEART JOURNAL (2011)
The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices
Pedro Plans-Rubio
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2010)
Pleiotropic Effects of Statins Evidence Against Benefits Beyond LDL-Cholesterol Lowering
Terje R. Pedersen
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2010)
Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial
Thomas M. S. Wolever et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
A Framework for Public Health Action: The Health Impact Pyramid
Thomas R. Frieden
AMERICAN JOURNAL OF PUBLIC HEALTH (2010)
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
Robert J. Glynn et al.
ANNALS OF INTERNAL MEDICINE (2010)
Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis
Devin M. Mann et al.
ANNALS OF PHARMACOTHERAPY (2010)
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
M. J. L. Peters et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Statins and All-Cause Mortality in High-Risk Primary Prevention A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants
Kausik K. Ray et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products Buyer Beware!
Ram Y. Gordon et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
Eric Bruckert et al.
ATHEROSCLEROSIS (2010)
Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America
Simon Capewell et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2010)
The Epidemiology of Excess Mortality in People With Mental Illness
David Lawrence et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2010)
Cardiovascular Risk-Estimation Systems in Primary Prevention Do They Differ? Do They Make a Difference? Can We See the Future?
Marie Therese Cooney et al.
CIRCULATION (2010)
Effect of Hydroxymethylglutaryl Coenzyme-A Reductase Inhibitors on the Long-Term Progression of Rheumatic Mitral Valve Disease
Francesco Antonini-Canterin et al.
CIRCULATION (2010)
Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial
Kwan Leung Chan et al.
CIRCULATION (2010)
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives
Qian Zhou et al.
CIRCULATION JOURNAL (2010)
Results of a Retrospective Database Analysis of Adherence to Statin Therapy and Risk of Nonfatal Ischemic Heart Disease in Daily Clinical Practice in Italy
Giovanni Corrao et al.
CLINICAL THERAPEUTICS (2010)
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes
M. -R. Taskinen et al.
DIABETOLOGIA (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials
S. S. AbuMweis et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2010)
Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus - A pooled meta-analysis of randomized placebo-controlled clinical trials
Sandeep A. Saha et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Efficacy of High-Dose Atorvastatin Loading Before Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction The STATIN STEMI Trial
Jung-Sun Kim et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Genetically Elevated Apolipoprotein A-I, High-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease
Christiane L. Haase et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A systematic review and meta-analysis on the therapeutic equivalence of statins
T. -C. Weng et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database
Philip J. Barter et al.
JOURNAL OF LIPID RESEARCH (2010)
Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis
Alex J. Mitchell et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
Klas Gransbo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The Metabolic Syndrome and Cardiovascular Risk A Systematic Review and Meta-Analysis
Salvatore Mottillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
Kunihiro Matsushita et al.
LANCET (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
LANCET (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
Min Jun et al.
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Impact of Adherence to Antihypertensive Agents on Clinical Outcomes and Hospitalization Costs
Alice Dragomir et al.
MEDICAL CARE (2010)
Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.
Emily Y. Chew et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Analysing the Large Decline in Coronary Heart Disease Mortality in the Icelandic Population Aged 25-74 between the Years 1981 and 2006
Thor Aspelund et al.
PLOS ONE (2010)
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
M. John Chapman et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Dariush Mozaffarian et al.
PLOS MEDICINE (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium
Mattias Neyt et al.
ACTA CARDIOLOGICA (2009)
Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
Xue-Qiao Zhao et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention
Jose M. Ordovas
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart Disease
Andrew Mente et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With Fenofibrate
Marja-Riitta Taskinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins
Cesare R. Sirtori et al.
ATHEROSCLEROSIS (2009)
HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk
M. T. Cooney et al.
ATHEROSCLEROSIS (2009)
Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States
Benjamin I. Goldstein et al.
BIPOLAR DISORDERS (2009)
Omega-6 Fatty Acids and Risk for Cardiovascular Disease A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention
William S. Harris et al.
CIRCULATION (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Targets of Statin Therapy: LDL Cholesterol, Non-HDL Cholesterol, and Apoliproprotein B in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)
Valentine Charlton-Menys et al.
CLINICAL CHEMISTRY (2009)
Severe hypertriglyceridemia and pancreatitis: presentation and management
Nils Ewald et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Russell Scott et al.
DIABETES CARE (2009)
Effects of a Plant-Based High-Carbohydrate/High-Fiber Diet Versus High-Monounsaturated Fat/Low-Carbohydrate Diet on Postprandial Lipids in Type 2 Diabetic Patients
Claudia De Natale et al.
DIABETES CARE (2009)
Combination statin-fibrate therapy: safety aspects
R. Franssen et al.
DIABETES OBESITY & METABOLISM (2009)
Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002
Lena Bjorck et al.
EUROPEAN HEART JOURNAL (2009)
Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies
Marie-Therese Cooney et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators
Marie Therese Cooney et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
Health effects of trans-fatty acids: experimental and observational evidence
D. Mozaffarian et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2009)
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
M. De Hert et al.
EUROPEAN PSYCHIATRY (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Kimber L. Stanhope et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Risk Factors for Development of Coronary Artery Disease in Women with Systemic Lupus Erythematosus
Robert J. Goldberg et al.
JOURNAL OF RHEUMATOLOGY (2009)
Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial
Germano Di Sciascio et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Novel Approaches for Preventing or Limiting Events (Naples) II Trial Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction
Carlo Briguori et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk A Review for Clinicians
Marie Therese Cooney et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Contraceptive Hormone Use and Cardiovascular Disease
Chrisandra L. Shufelt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Meta-Analysis of the Relationship Between Non-High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
Jennifer G. Robinson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
Jari Tiihonen et al.
LANCET (2009)
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
Pierre Amarenco et al.
LANCET NEUROLOGY (2009)
Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery.
Olaf Schouten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt C. Fellstroem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impact of progressive resistance training on lipids and lipoproteins in adults: Another look at a meta-analysis using prediction intervals
George A. Kelley et al.
PREVENTIVE MEDICINE (2009)
The Efficacy and Tolerability of Ezetimibe in Cardiac Transplant Recipients Taking Cyclosporin
Steven M. Shaw et al.
TRANSPLANTATION (2009)
The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients
Spencer B. Cherry et al.
VALUE IN HEALTH (2009)
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
J. J. Brugts et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Effect of Xuezhikang, an extract from red yeast chinese rice, on coronary events in a Chinese population with previous myocardial infarction
Zongliang Lu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk
B. Greg Brown et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Relative safety of Gemfibrozil and Fenofibrate in the absence of concomitant Cerivastatin use
Noa Holoshitz et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Mechanism of action of niacin
Vaijinath S. Kamanna et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)
Ingar Holme et al.
ANNALS OF MEDICINE (2008)
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
Martin Adiels et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction The Reynolds Risk Score for Men
Paul M. Ridker et al.
CIRCULATION (2008)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy
David A. Wohl et al.
CLINICAL INFECTIOUS DISEASES (2008)
Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes
Angela A. Rivellese et al.
CLINICAL NUTRITION (2008)
Long-Term Persistence with Statin Treatment in a Not-for-Profit Health Maintenance Organization: A Population-Based Retrospective Cohort Study in Israel
Gabriel Chodick et al.
CLINICAL THERAPEUTICS (2008)
Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men
Piia Peura et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
The Residual Risk Reduction Initiative: a call to action to residual vascular risk in dyslipidaemic patients
Jean-Charles Fruchart et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study
Pirjo Ilanne-Parikka et al.
DIABETES CARE (2008)
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Edward J. Mills et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial
D. A. Wood et al.
LANCET (2008)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
Anne B. Rossebo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Non-pharmacological control of plasma cholesterol levels
Andrea Poli et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2008)
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Statins are effective in treating dyslipidemia among psychiatric patients using second-generation antipsychotic agents
Kari Ojala et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Rosuvastatin in older patients with systolic heart failure
John Kjekshus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
A. C. Keech et al.
LANCET (2007)
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Philip Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
Erik Ingelsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Diabetes and mortality following acute coronary syndromes
Sean M. Donahoe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Sandeep Bansal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Borge G. Nordestgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease
Nanette K. Wenger et al.
ANNALS OF INTERNAL MEDICINE (2007)
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
Virginia A. Triant et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)
Samia Mora et al.
ATHEROSCLEROSIS (2007)
Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome
Jing Liu et al.
AMERICAN HEART JOURNAL (2007)
Safety considerations with fibrate therapy
Michael H. Davidson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Safety considerations with niacin therapy
John R. Guyton et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women - The Reynolds Risk Score
Paul M. Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease - Results of the Study Assessing Goals in the Elderly (SAGE)
Prakash Deedwania et al.
CIRCULATION (2007)
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effect of high-dose atorvastatin on hospitalizations for heart failure - Subgroup analysis of the treating to new targets (TNT) study
Kiran K. Khush et al.
CIRCULATION (2007)
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
Mark Woodward et al.
HEART (2007)
Triglycerides and the risk of coronary heart disease - 10 158 incident cases among 262 525 participants in 29 Western prospective studies
Nadeem Sarwar et al.
CIRCULATION (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection
J. Dinnes et al.
HEALTH TECHNOLOGY ASSESSMENT (2007)
Abdominal aortic aneurysm - Pathogenesis and implications for management
Jonathan Golledge et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review
Ethan M. Balk et al.
ATHEROSCLEROSIS (2006)
Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
Thomas A. Gaziano et al.
LANCET (2006)
Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
Chris J. Packard
CURRENT OPINION IN LIPIDOLOGY (2006)
Safety evaluation of phytosterol-esters. Part 9: Results of a European post-launch monitoring programme
L. J. Lea et al.
FOOD AND CHEMICAL TOXICOLOGY (2006)
Low density lipoprotein cholesterol, statins and cardiovascular events:: a meta-analysis
B. Genser et al.
CLINICAL RESEARCH IN CARDIOLOGY (2006)
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study
BM Scirica et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies
A Thompson et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Statin safety: An assessment using an administrative claims database
MJ Cziraky et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Statin safety: An appraisal from the adverse event reporting system
MH Davidson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Statin safety: A systematic review
M Law et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
L Hooper et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Clinical review: A critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations
A Dewell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age
DM Lloyd-Jones et al.
CIRCULATION (2006)
Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors - A meta-analysis of randomized controlled trials
AJ Nordmann et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery?
K. I. Paraskevas et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2006)
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study
E Bruckert et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction - The IDEAL study: A randomized controlled trial
TR Pedersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes
KK Ray et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease
E Tedeschi-Reiner et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis
SJ Cowell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Impact of medication adherence on hospitalization risk and healthcare cost
MC Sokol et al.
MEDICAL CARE (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation
M Ferrario et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2005)
Medication adherence trends with statins
MA Huser et al.
ADVANCES IN THERAPY (2005)
Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes
RAJ Vuppalanchi et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2005)
Drug therapy in the heart transplant recipient - Part IV: Drug-drug interactions
RL Page et al.
CIRCULATION (2005)
Reduction in cardiovascular events after vascular surgery with atorvastatin: A randomized trial
AES Durazzo et al.
JOURNAL OF VASCULAR SURGERY (2004)
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
N Chalasani et al.
GASTROENTEROLOGY (2004)
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial
JA de Lemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells
JE Sidaway et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Statins in stroke prevention and carotid atherosclerosis -: Systematic review and up-to-date meta-analysis
P Amarenco et al.
STROKE (2004)
Beneficial cardiovascular pleiotropic effects of statins
J Davignon
CIRCULATION (2004)
Drug treatment of hyperlipidemia in women
JME Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Effect of statins on the progression of bioprosthetic aortic valve degeneration
F Antonini-Canterin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease
MM McDermott et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis
K Maeda et al.
PREVENTIVE MEDICINE (2003)
Estrogen plus progestin and the risk of coronary heart disease
JE Manson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A strategy to reduce cardiovascular disease by more than 80%
NJ Wald et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Impact of HIV infection and HAART on serum lipids in men
SA Riddler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
SP Laing et al.
DIABETOLOGIA (2003)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
A Onat et al.
ATHEROSCLEROSIS (2003)
Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART
L Calza et al.
AIDS (2003)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects
AA Rivellese et al.
ATHEROSCLEROSIS (2003)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Effects of the amount and intensity of exercise on plasma lipoproteins
WE Kraus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study
L Wei et al.
HEART (2002)
Myocardial infarction and third generation oral contraceptives: aggregation of recent studies
WO Spitzer et al.
HUMAN REPRODUCTION (2002)
Long-term persistence in use of statin therapy in elderly patients
JS Benner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
CA Jackevicius et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction - Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione
R Marchioli et al.
CIRCULATION (2002)
Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men?: The Reykjavik Study
LS Jónsdóttir et al.
JOURNAL OF CARDIOVASCULAR RISK (2002)
Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families - Results of a 5-year follow-up study
MJ Veerkamp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study
G Assmann et al.
CIRCULATION (2002)
Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S
CM Ballantyne et al.
CIRCULATION (2001)
Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial
D Hunt et al.
ANNALS OF INTERNAL MEDICINE (2001)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
GG Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women:: The KANWU study
B Vessby et al.
DIABETOLOGIA (2001)
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
FM Sacks et al.
CIRCULATION (2000)
Share Paper
